High Growth Reported for the World Smoking Cessation Aids Market

Business Wire, Nov 25, 2008

NEW YORK -- Reportlinker.com announces that a new market research report related to the Personal care industry is available in its catalogue.

World Smoking Cessation Aids Market

http://www.reportlinker.com/p090576/World-Smoking-Cessation-Aids-Market.html

This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges & tablets, and Others (Nicotine Inhaler, and Nasal Spray). The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 32 companies including many key and niche players worldwide such as GlaxoSmithKline Plc, Johnson & Johnson Inc., Novartis Consumer Healthcare Inc., Perrigo Company, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SMOKING CESSATION AIDS MCP-1591 A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-2 Product Definition and Scope of Study I-3 Smoking Cessation Aids I-3 Definitions I-3 A. Nicotine Gum I-3 B. Nicotine Patch I-4 C. Nicotine Lozenges And Tablets I-4 D. Others I-4 Nicotine Inhaler I-4 Nicotine Nasal Spray I-4

II. EXECUTIVE SUMMARY

1. Industry Outlook II-1 Leading Players II-1 Tobacco Products Industry: An Introduction II-1 Regulations/Taxes II-2 Black Market II-2 Cigarette: The Tobacco King II-3 Cigars: All Rolled Up II-3 Glut of Products Restrain Growth II-3 Major Cigar Tobacco Producing Regions II-3 China Dominates the Cigarettes Sector II-4 Competitive Scenario II-4

Table 1: World Cigarettes Market for 2004 & 2005: Market Shares Based on Volume Sales of Leading Manufacturers for Philip Morris, British American Tobacco, Japan Tobacco, Imperial Tobacco, Gallaher, Reynolds American and Others (includes corresponding Graph/Chart) II-4

Table 2: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Billion Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart) II-5

Table 3: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart) II-5

Table 4: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2000 2006 and 2010 (includes corresponding Graph/Chart) II-6

Table 5: World Recent Past, Current & Future Analysis for Cigars by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart) II-6 Why to Quit Smoking II-7 Secondhand Smoke II-7 Why Smoking is Hard to Quit II-7 Methods of Smoking Cessations II-8 Cold Turkey II-8 Drug Therapies II-9 Other Interventions II-9 Benefits of Quitting Smoking II-9

2. World Smoking Statistics II-11

3. Product Overview II-12 Smoking Cessation Aids Defined II-12 Nicotine Gum II-12 Factors to Consider II-12 Effectiveness of Nicotine Gum II-13 Nicotine Patch II-13 Factors to Consider II-14 Nicotine Lozenges & Tablets II-14 Factors to Consider II-15 Other Smoking Cessation Aids II-15 Nicotine Inhaler II-15 Factors to Consider II-15 Nicotine Nasal Spray II-16 Factors to Consider II-16 Non-Nicotine Based Medications II-16

4. Trends and Issues II-17 Inundate Anti-Smoking Vaccines Kindles Underdeveloped Prescription Market II-17 Strict Regulations Deter Smoking Cessation Aids II-17 Growing Anti Smoking Campaigns II-18 Health Concerns II-18 Corporations Initiate for Smoke Free Work Environment II-18 Television Advertisements - Most Effective Media for Smoking Cessation II-19 Public Awareness through Internet II-19 Rising Prices of Tobacco - A Key Strategy for Quitting Smoking II-19

5. Product Innovations/Introductions II-20 Acomplia to Enter Smoking Cessation Market II-20 Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US Market II-20 Nicodrops Unveils New Lozenge for Smoking Cessation II-20 Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan II-20 Glaxo Unveils First Anti-Smoking Medicine in India II-20

6. Recent Industry Activity II-21 Pfizer Japan to Roll Out Champix Anti-Smoking Drug II-21 Inverness Medical Innovations Pockets Bio-Stat Healthcare Group II-21 Novartis New Smoking Cessation Aids Gets FDA's Approval II-21 Johnson & Johnson Concludes Take Over of Pfizer Consumer Healthcare II-21 Pfizer Receives FDA Approval for Smoking Cessation Medicine Chantix[TM] II-22 Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum II-22 Pfizer Receives Chinese Approval for Clinical Trials on Smoking Cessation Aid II-22 Pfizer Receives EC Approval for New Varenicline II-22 Formation of Sanofi-Aventis II-22 AXIA Health Management Acquires Smoking Cessation Website II-23 Nicodrops Receives EC Approval for Smoking Cessation Aid II-23 Nabi Unveils Successful Phase II Results for Smoking Cessation Vaccine II-23 FDA Grants Approval for High Strength Bupropion II-23 Watson Pharmaceuticals Receives Rights to Market Zyban[R] II-24 Pfizer Merges with Pharmacia II-24 FDA Approves Anti-Smoking Medication for OTC Sales II-24 GSK and Taisho to Develop Anti-Smoking Medication II-24 Johnson & Johnson Acquires Alza II-24